Index
RUI
Market Cap
39.64B
Enterprise Value
38.79B
Income
-164.71M
Sales
2.91B
Book/sh
12.95
Cash/sh
7.57
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6140
IPO
Jul 02, 2015
P/E
-
Forward P/E
-
PEG
-
P/S
13.63
P/B
21.11
P/C
36.13
P/FCF
755.56
EV/EBITDA
-
EV/Sales
13.33
Quick Ratio
2.66
Current Ratio
2.81
Debt/Eq
0.13
LT Debt/Eq
0.08
Option/Short
Yes / Yes
EPS (ttm)
-1.15
EPS next Y
-0.52
EPS next Q
-0.16
EPS this Y
-6.79%
EPS next Y
67.74%
EPS next 5Y
-
EPS past 3/5Y
35.09% 11.70%
Sales past 3/5Y
41.14% 42.61%
EPS Y/Y TTM
49.82%
Sales Y/Y TTM
37.43%
EPS Q/Q
34.82%
Sales Q/Q
34.08%
Insider Own
6.42%
Insider Trans
-6.64%
Inst Own
93.02%
Inst Trans
5.08%
ROA
-7.21%
ROE
-10.55%
ROIC
-8.19%
Gross Margin
64.50%
Oper. Margin
-8.82%
Profit Margin
-5.66%
SMA20
-21.28%
SMA50
-27.19%
SMA200
0.13%
Trades
Shs Outstand
144.34M
Shs Float
135.69M
52W High
437.41 -37.50%
52W Low
181.00 51.05%
Volatility
6.35% 5.87%
ATR (14)
20.96
RSI (14)
26.15
Beta
1.64
Rel Volume
0.78
Avg Volume
1.77M
Volume
1,384,642
Perf Week
-14.32%
Perf Month
-31.88%
Perf Quarter
-16.58%
Perf Half Y
34.55%
Perf YTD
19.34%
Perf Year
21.21%
Perf 3Y
399.00%
Perf 5Y
164.97%
Perf 10Y
2182.14%
Prev Close
289.92
Price
273.40
Change %
-5.70%
Analysts 17 incl. previous ratings
Rating Distribution 15 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 23, 2026 Initiated R Roth Capital
Buy $475 +73.7% Sep 09, 2026 Resumed U UBS
Buy $435 +59.1% Sep 08, 2026 Initiated R Rothschild & Co Redburn
Buy $385 +40.8% Jun 26, 2026 Resumed B Bernstein
Outperform $310 +13.4% Jun 12, 2026 Resumed R RBC Capital Mkts
Outperform $275 +0.6% Jun 02, 2026 Resumed W Wolfe Research
Outperform $260 -4.9% Apr 14, 2026 Initiated W William Blair
Outperform Jan 07, 2026 Initiated C Citigroup
Buy $300 +9.7% Dec 02, 2025 Resumed M Morgan Stanley
Overweight $265 -3.1% Oct 27, 2025 Upgrade B BNP Paribas Exane
Underperform → Neutral $172 -37.1% Sep 22, 2025 Resumed W Wells Fargo
Equal Weight $175 -36.0% Mar 13, 2025 Initiated R RBC Capital Mkts
Outperform $251 -8.2% Jan 23, 2025 Initiated B Barclays
Overweight $200 -26.8% Jun 03, 2024 Resumed J Jefferies
Buy $142 -48.1% Apr 08, 2024 Resumed C Craig Hallum
Buy $117 -57.2% Feb 20, 2024 Downgrade R Raymond James
Strong Buy → Outperform $68 → $85 -68.9% Dec 29, 2023 Reiterated B BTIG Research
Buy $75 → $85 -68.9% Dec 14, 2023 Initiated G Guggenheim
Buy $70 -74.4% Dec 13, 2023 Initiated W Wolfe Research
Outperform $70 -74.4% Nov 13, 2023 Upgrade R Raymond James
Outperform → Strong Buy $68 -75.1%
Show Previous Ratings
Today 08:00AM
Nov-17-26 10:45AM
Nov-11-26 06:19AM
Nov-10-26 06:00AM
Nov-06-26 12:46PM
08:59PM
Loading…
Nov-05-26 08:59PM
(Earnings Whispers)
-6.97%
05:23PM
03:06PM
03:05PM
06:00AM
Nov-04-26 06:00AM
Nov-03-26 07:00AM
Oct-29-26 12:24PM
08:00AM
04:03AM
07:45AM
Loading…
Oct-27-26 07:45AM
Oct-26-26 07:00AM
Oct-18-26 06:10PM
Oct-15-26 12:46PM
Oct-13-26 07:30AM
Oct-09-26 10:19AM
08:41AM
08:00AM
Oct-07-26 08:00AM
Oct-06-26 08:00AM
Oct-05-26 10:05AM
08:00AM
Sep-22-26 01:50PM
08:00AM
Sep-18-26 06:00AM
06:00AM
Loading…
Sep-01-26 06:00AM
Aug-28-26 11:03AM
Aug-24-26 02:23PM
Aug-17-26 11:55AM
Aug-14-26 06:05PM
Aug-12-26 06:00AM
Aug-07-26 01:55PM
10:42AM
01:09AM
Aug-06-26 05:30PM
(Associated Press)
-3.36%
Aug-05-26 06:00AM
Aug-03-26 04:06PM
Jul-30-26 08:00AM
Jul-22-26 06:00AM
Jul-20-26 12:06PM
Jul-16-26 06:35PM
08:13AM
Jul-13-26 12:52PM
Jul-10-26 08:57AM
Jul-09-26 06:00AM
Jul-06-26 06:00AM
Jul-02-26 06:41PM
Jul-01-26 06:02PM
05:41PM
Jun-29-26 06:00AM
Jun-25-26 07:00AM
Jun-24-26 05:00AM
Jun-23-26 06:00AM
Jun-18-26 06:00AM
Jun-05-26 10:40AM
09:36AM
Jun-04-26 08:00AM
Jun-03-26 08:00AM
May-29-26 06:00AM
May-28-26 06:00AM
May-26-26 06:00AM
May-21-26 05:05PM
07:00AM
May-20-26 04:51PM
07:00AM
May-15-26 05:18PM
(GuruFocus.com)
-5.36%
+3.32%
12:45PM
12:01AM
May-14-26 05:30AM
(The Wall Street Journal)
May-07-26 05:22PM
(Associated Press)
-11.64%
04:05PM
May-06-26 09:31AM
Apr-30-26 08:00AM
Apr-23-26 12:33PM
Apr-22-26 09:00AM
Apr-13-26 08:00AM
Apr-09-26 06:00AM
Apr-07-26 06:00AM
Mar-31-26 06:00AM
Mar-16-26 06:00AM
Mar-12-26 08:00AM
08:00AM
Mar-09-26 12:41AM
Mar-04-26 07:10AM
Mar-03-26 03:35PM
Feb-27-26 12:40PM
10:05AM
12:07AM
12:05AM
Feb-26-26 11:53PM
06:45PM
06:30PM
04:58PM
(Associated Press Finance)
04:05PM
Feb-24-26 10:28PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sheena Jonathan CO-FOUNDER Nov 11 '26 Sale 319.30 1,500 478,945 7,500 Nov 13 09:05 PM Sheena Jonathan CO-FOUNDER Nov 06 '26 Sale 316.00 3,150 995,405 214,462 Nov 10 09:05 PM Sheena Jonathan CO-FOUNDER Nov 02 '26 Sale 399.97 112 44,797 217,574 Nov 04 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Nov 02 '26 Sale 400.02 748 299,214 2,116,928 Nov 04 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Nov 02 '26 Sale 400.05 341 136,416 167,880 Nov 04 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Nov 02 '26 Sale 409.77 3,419 1,400,994 101,323 Nov 04 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Nov 02 '26 Sale 400.01 302 120,804 195,276 Nov 04 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Nov 02 '26 Sale 411.80 3,801 1,565,239 87,431 Nov 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Nov 03 '26 Sale 391.49 470 184,000 45,779 Nov 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Nov 02 '26 Sale 399.99 325 129,998 46,249 Nov 04 09:35 PM MICHAEL BROPHY Officer Nov 03 '26 Proposed Sale 378.92 470 178,092 Nov 03 04:31 PM STEVEN L CHAPMAN Officer Nov 02 '26 Proposed Sale 415.64 2,866 1,191,224 Nov 02 04:14 PM JONATHAN SHEENA DIRECTOR Nov 02 '26 Proposed Sale 414.30 108 44,744 Nov 02 04:06 PM MATTHEW RABINOWITZ DIRECTOR Nov 02 '26 Proposed Sale 414.30 722 299,125 Nov 02 04:06 PM DANIEL RABINOWITZ OFFICER Nov 02 '26 Proposed Sale 414.30 330 136,719 Nov 02 04:05 PM SOLOMON MOSHKEVICH OFFICER Nov 02 '26 Proposed Sale 414.30 405 167,792 Nov 02 04:05 PM JOHN FESKO OFFICER Nov 02 '26 Proposed Sale 414.30 291 120,561 Nov 02 04:05 PM STEVEN CHAPMAN OFFICER Nov 02 '26 Proposed Sale 414.30 903 374,113 Nov 02 04:05 PM MICHAEL BROPHY OFFICER Nov 02 '26 Proposed Sale 414.30 313 129,676 Nov 02 04:04 PM SOLOMON MOSHKEVICH Officer Nov 02 '26 Proposed Sale 411.13 3,000 1,233,380 Nov 02 04:03 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 30 '26 Sale 425.55 1,906 811,098 46,574 Oct 30 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 28 '26 Sale 426.46 1,178 502,372 48,480 Oct 30 09:35 PM MICHAEL BROPHY Officer Oct 30 '26 Proposed Sale 436.00 1,906 831,016 Oct 30 04:21 PM Sheena Jonathan CO-FOUNDER Oct 27 '26 Sale 406.00 291 118,146 217,873 Oct 29 09:35 PM Sheena Jonathan CO-FOUNDER Oct 28 '26 Sale 426.34 187 79,726 217,686 Oct 29 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Oct 27 '26 Sale 406.00 1,718 697,508 2,117,676 Oct 29 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Oct 28 '26 Sale 426.34 968 412,698 168,221 Oct 29 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Oct 27 '26 Sale 406.00 884 358,904 169,189 Oct 29 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Oct 28 '26 Sale 426.34 1,162 495,408 104,742 Oct 29 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Oct 27 '26 Sale 406.00 1,010 410,060 105,904 Oct 29 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Oct 28 '26 Sale 426.34 898 382,854 195,578 Oct 29 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Oct 27 '26 Sale 406.00 781 317,086 196,476 Oct 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Oct 28 '26 Sale 426.34 3,430 1,462,348 91,232 Oct 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Oct 27 '26 Sale 406.00 2,264 919,184 94,662 Oct 29 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 28 '26 Sale 426.34 1,198 510,756 49,658 Oct 29 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 27 '26 Sale 406.00 781 317,086 50,856 Oct 29 09:35 PM MICHAEL BROPHY Officer Oct 28 '26 Proposed Sale 410.82 1,178 483,946 Oct 28 05:58 PM JONATHAN SHEENA DIRECTOR Oct 28 '26 Proposed Sale 410.82 191 78,467 Oct 28 04:19 PM DANIEL RABINOWITZ OFFICER Oct 28 '26 Proposed Sale 410.82 988 405,890 Oct 28 04:18 PM SOLOMON MOSHKEVICH OFFICER Oct 28 '26 Proposed Sale 410.82 1,185 486,822 Oct 28 04:18 PM JOHN FESKO OFFICER Oct 28 '26 Proposed Sale 410.82 917 376,722 Oct 28 04:18 PM STEVEN CHAPMAN OFFICER Oct 28 '26 Proposed Sale 410.82 3,499 1,437,459 Oct 28 04:17 PM MICHAEL BROPHY OFFICER Oct 28 '26 Proposed Sale 410.82 1,222 502,022 Oct 28 01:14 PM JONATHAN SHEENA DIRECTOR Oct 27 '26 Proposed Sale 404.90 287 116,206 Oct 27 04:14 PM MATTHEW RABINOWITZ DIRECTOR Oct 27 '26 Proposed Sale 404.90 1,697 687,115 Oct 27 04:14 PM DANIEL RABINOWITZ OFFICER Oct 27 '26 Proposed Sale 404.90 873 353,478 Oct 27 04:14 PM SOLOMON MOSHKEVICH OFFICER Oct 27 '26 Proposed Sale 404.90 997 403,685 Oct 27 04:13 PM JOHN FESKO OFFICER Oct 27 '26 Proposed Sale 404.90 771 312,178 Oct 27 04:13 PM STEVEN CHAPMAN OFFICER Oct 27 '26 Proposed Sale 404.90 2,236 905,356 Oct 27 04:12 PM MICHAEL BROPHY OFFICER Oct 27 '26 Proposed Sale 404.90 771 312,178 Oct 27 04:08 PM Sheena Jonathan CO-FOUNDER Oct 21 '26 Sale 410.55 3,150 1,293,246 218,164 Oct 23 09:25 PM Sheena Jonathan Director Oct 21 '26 Proposed Sale 410.55 9,450 3,879,737 Oct 21 01:09 PM Sheena Jonathan CO-FOUNDER Oct 16 '26 Sale 402.47 1,500 603,710 8,250 Oct 20 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Oct 15 '26 Option Exercise 10.41 50,000 520,500 2,169,394 Oct 16 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Oct 15 '26 Sale 402.64 50,000 20,132,028 2,119,394 Oct 16 09:35 PM MATTHEW RABINOWITZ Director Oct 15 '26 Proposed Sale 394.75 50,000 19,737,500 Oct 15 04:18 PM Chapman Steven Leonard CEO AND PRESIDENT Oct 01 '26 Sale 413.31 1,273 526,144 96,926 Oct 02 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Oct 01 '26 Sale 414.22 3,000 1,242,645 106,914 Oct 02 09:35 PM STEVEN L CHAPMAN Officer Oct 01 '26 Proposed Sale 413.31 1,273 526,144 Oct 01 04:24 PM SOLOMON MOSHKEVICH Officer Oct 01 '26 Proposed Sale 414.22 3,000 1,242,645 Oct 01 04:04 PM Sheena Jonathan CO-FOUNDER Sep 23 '26 Sale 388.01 18,064 7,008,972 9,000 Sep 25 09:35 PM Sheena Jonathan Director Sep 23 '26 Proposed Sale 387.55 21,064 8,163,402 Sep 23 10:58 AM Sheena Jonathan CO-FOUNDER Sep 15 '26 Sale 350.07 6,000 2,100,431 224,464 Sep 17 09:35 PM Sheena Jonathan CO-FOUNDER Sep 16 '26 Sale 354.19 3,150 1,115,714 221,314 Sep 17 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Sep 15 '26 Sale 347.19 50,000 17,359,280 2,125,394 Sep 16 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Sep 14 '26 Sale 334.76 50,000 16,737,977 2,175,394 Sep 16 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Sep 15 '26 Sale 350.01 2,000 700,014 0 Sep 16 09:35 PM TINKERBELLE II TR U/A DTD 10/2 Officer Sep 15 '26 Proposed Sale 350.01 2,000 700,015 Sep 15 04:53 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Sep 11 '26 Sale 327.97 50,000 16,398,267 2,225,394 Sep 11 09:35 PM MATTHEW RABINOWITZ Director Sep 11 '26 Proposed Sale 326.14 200,000 65,228,000 Sep 11 04:28 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sep 02 '26 Sale 326.89 15,160 4,955,713 110,859 Sep 03 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sep 01 '26 Sale 320.73 3,000 962,194 126,019 Sep 03 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Sep 01 '26 Sale 320.99 1,698 545,041 98,199 Sep 03 09:05 PM STEVEN L CHAPMAN Officer Sep 01 '26 Proposed Sale 320.99 1,698 545,041 Sep 01 04:08 PM SOLOMON MOSHKEVICH Officer Sep 01 '26 Proposed Sale 320.73 3,000 962,194 Sep 01 04:05 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Aug 10 '26 Sale 321.53 6,517 2,095,411 197,257 Aug 28 09:35 PM Sheena Jonathan CO-FOUNDER Aug 10 '26 Sale 325.32 6,000 1,951,942 230,464 Aug 14 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Aug 07 '26 Sale 320.90 2,000 641,800 2,000 Aug 07 09:35 PM Sheena Jonathan CO-FOUNDER Aug 07 '26 Sale 315.66 9,150 2,888,325 236,464 Aug 07 09:35 PM TINKERBELLE II TR U/A DTD 10/2 Officer Aug 07 '26 Proposed Sale 320.90 2,000 641,800 Aug 07 05:42 PM Sheena Jonathan Director Aug 07 '26 Proposed Sale 330.62 18,000 5,951,100 Aug 07 10:41 AM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Aug 04 '26 Sale 274.22 478 131,077 51,637 Aug 05 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Aug 03 '26 Sale 267.99 317 84,953 52,115 Aug 05 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Aug 03 '26 Sale 266.39 3,076 819,431 99,897 Aug 05 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Aug 03 '26 Sale 267.99 295 79,057 183,774 Aug 05 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Aug 03 '26 Sale 265.58 3,410 905,627 129,019 Aug 05 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Aug 03 '26 Sale 267.99 334 89,508 170,073 Aug 05 09:35 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Aug 03 '26 Sale 267.99 731 195,900 2,275,394 Aug 05 09:35 PM Sheena Jonathan CO-FOUNDER Aug 03 '26 Sale 267.99 109 29,211 245,614 Aug 05 09:35 PM MICHAEL BROPHY Officer Aug 04 '26 Proposed Sale 270.36 478 129,232 Aug 04 04:36 PM JONATHAN SHEENA OFFICER Aug 03 '26 Proposed Sale 267.76 108 28,918 Aug 03 04:22 PM MATTHEW RABINOWITZ OFFICER Aug 03 '26 Proposed Sale 267.76 722 193,323 Aug 03 04:22 PM DANIEL RABINOWITZ OFFICER Aug 03 '26 Proposed Sale 267.76 330 88,361 Aug 03 04:22 PM SOLOMON MOSHKEVICH OFFICER Aug 03 '26 Proposed Sale 267.76 405 108,443 Aug 03 04:21 PM JOHN FESKO OFFICER Aug 03 '26 Proposed Sale 267.76 292 78,186 Aug 03 04:21 PM STEVEN CHAPMAN OFFICER Aug 03 '26 Proposed Sale 267.76 1,167 312,476 Aug 03 04:21 PM MICHAEL BROPHY OFFICER Aug 03 '26 Proposed Sale 267.76 313 83,809 Aug 03 04:20 PM STEVEN L CHAPMAN Officer Aug 03 '26 Proposed Sale 265.40 1,894 502,668 Aug 03 04:18 PM SOLOMON MOSHKEVICH Officer Aug 03 '26 Proposed Sale 265.25 3,000 795,751 Aug 03 04:09 PM Sheena Jonathan CO-FOUNDER Jul 27 '26 Sale 260.49 288 75,021 245,914 Jul 29 09:35 PM
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Co-Founder & Executive Chairman Dr. Matthew Rabinowitz Ph.D.
CEO & Director Mr. Steven Leonard Chapman
President & Chief Business Officer Mr. John Fesko
Chief Financial Officer Mr. Michael B. Brophy M.B.A.
President of Clinical Diagnostics Mr. Solomon Moshkevich M.B.A.